sq-11725 has been researched along with ovalbumin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganea, D; Jonakait, GM; Vega, JL | 1 |
| Bond, RA; Dudekula, NB; Knoll, BJ; Lin, R; Nguyen, LP; Parra, S; Peng, H; Shardonofsky, F | 1 |
| Ammar-Aouchiche, Z; Bond, RA; Clement, C; Dickey, BF; Ehre, C; Frieske, JM; Ho, SB; Kesimer, M; Knoll, BJ; Nguyen, LP; Omoluabi, O; Parra, S; Tuvim, MJ | 1 |
| Chupp, GL | 1 |
| Bond, RA; Bouvier, M; Forkuo, GS; Joshi, R; Knoll, BJ; Leff, P; Parra, S; Thanawala, VJ; Valdez, DJ | 1 |
| Bond, RA; Eikenburg, DC; Joshi, R; Kim, H; Knoll, BJ; Valdez, D | 1 |
6 other study(ies) available for sq-11725 and ovalbumin
| Article | Year |
|---|---|
Acute down-regulation of antibody production following spinal cord injury: role of systemic catecholamines.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antibodies, Anti-Idiotypic; Antibody Formation; Catecholamines; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Laminectomy; Nadolol; Ovalbumin; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Subarachnoid Space; Superior Cervical Ganglion; Sympathectomy; Time Factors | 2003 |
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Asthma; Blotting, Western; Bronchial Provocation Tests; Drug Administration Schedule; Fluorescent Antibody Technique; Intracellular Signaling Peptides and Proteins; Male; Methacholine Chloride; Metoprolol; Mice; Mice, Inbred BALB C; Nadolol; Ovalbumin; Propanolamines; Receptors, Adrenergic, beta-2 | 2008 |
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Disease Models, Animal; Female; Inflammation; Infusion Pumps; Injections, Intraperitoneal; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mucins; Nadolol; Ovalbumin; Propanolamines; Specific Pathogen-Free Organisms | 2008 |
Say what, beta-blockers for asthma?
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Infusion Pumps; Injections, Intraperitoneal; Mice; Mucins; Nadolol; Ovalbumin; Propanolamines; Reproducibility of Results | 2008 |
β-Blockers have differential effects on the murine asthma phenotype.
Topics: Adrenergic beta-Antagonists; Allergens; Alprenolol; Animals; Asthma; Bronchoalveolar Lavage Fluid; Carbazoles; Carvedilol; Cell Count; Epinephrine; Female; Male; Mice, Knockout; Models, Biological; Mucins; Nadolol; Ovalbumin; Phenotype; Propanolamines; Propranolol | 2015 |
Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Carbazoles; Carvedilol; Disease Models, Animal; Inflammation; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nadolol; Ovalbumin; Phenotype; Phosphorylation; Propanolamines; Pyroglyphidae; Respiratory Hypersensitivity | 2017 |